Roberto Augusto Plaza Teixeira, Vicente Odone-Filho, Beatriz de Camargo, Maria Claudia Zerbini, Renne Fillipi, Arlaine Alencar, Lilian Cristofani
Department of Pediatric Oncology and Hematology, Universidade de São Paulo São Paulo, Brazil. rapteixeira@uol.com.br
Pediatric hematology and oncology 2011 AprFifteen percent of patients with Wilms' tumor (WT) experience relapse. It has been suggested that weight and age may affect the chances of relapse. Few studies have investigated the role, if any, between P-glycoprotein (P-gp) and relapse. The authors assessed the prognostic value of tumor weight and age at diagnosis and asked whether some other potential biological markers, specifically P-gp protein expression, had a prognostic value in favorable-histology WT. No association between age and relapse could be found. Patients with tumor weight ≥550 g were 6 times more likely to relapse, whereas P-gp expression was positive in 18/40 (45%) of the patients, of which 10/12 (83.3%) relapsed and 8/28 (28.6%) did not. Further studies are necessary to elucidate whether or not P-gp is related to relapse in patients with histologically favorable Wilms' tumor. If confirmed, the protein may be used in the future as a target for new drugs and treatments for this group of patients.
Roberto Augusto Plaza Teixeira, Vicente Odone-Filho, Beatriz de Camargo, Maria Claudia Zerbini, Renne Fillipi, Arlaine Alencar, Lilian Cristofani. P-glycoprotein expression, tumor weight, age, and relapse in patients with stage I and II favorable-histology Wilms' tumor. Pediatric hematology and oncology. 2011 Apr;28(3):194-202
PMID: 21214406
View Full Text